Neuromedin U2 receptor signaling mediates alteration of sleep-wake architecture in rats

Neuropeptides

Volumn 45, Issue 2, 2011, Pages 165-174

  Ahnaou, A ^a   Drinkenburg, W H I M ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

HPA axis; NmU2; Rat; Sleep disturbance; Stress

Indexed keywords

NEUROMEDIN U; NEUROMEDIN U 8; NEUROMEDIN U2 RECEPTOR; NEUROMEDIN U23; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ELECTRODE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP DEPRIVATION; SLEEP WAKING CYCLE; WAKEFULNESS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; HUMANS; MALE; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTRANSMITTER; SIGNAL TRANSDUCTION; SLEEP; STRESS, PHYSIOLOGICAL; WAKEFULNESS;

ANIMALIA; RATTUS; SUS;

EID: 79951517655     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2011.01.004     Document Type: Article

References (54)

1. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 1999, 160:1-12.
2. Augood S.J., Keast J.R., Emson P.C. Distribution and characterisation of neuromedin U-like immunoreactivity in rat brain and intestine and in guinea pig intestine. Regul. Pept. 1988, 20:281-292.
3. Austin C., Lo G., Nandha K.A., Meleagros L., Bloom S. Cloning and characterization of the cDNA encoding the human neuromedin U (NMU) precursor: NmU expression in the human gastrointestinal tract. J. Mol. Endocrinol. 1995, 14:157-169.
4. Ballesta J., Carlei F., Bishop A.E., Steel J.H., Gibson S.J., Fahey M., Hennessey R., Domin J., Bloom S.R., Polka J.M. Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 1988, 25:797-816.
5. Born J., Späth-Schwalbe E., Schwakenhofer H., Kern W., Fehm H.L. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J. Clin. Endocrinol. Metab. 1989, 68:904-911.
6. Brighton P.J., Szekeres P.G., Willars B. Neuromedin U and its receptors: structure, function, and physiological roles. Phramacol. Rev. 2004, 56:231-248.
7. Brown D.R., Quito F.L. Neuromedin U octapeptide alters ion transport in porcine jejunum. Eur. J. Pharmacol. 1988, 155:159-162.
8. Buckley T.H., Schatzberg A.F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J. Clin. Endocrinol. Metab. 2005, 90:3106-3114.
9. Chu C., Jin Q., Kunitake T., Kato K., Nabekura M., Nakazato T., Kangawa K., Kannan H. Cardiovascular actions of central neuromedin U in conscious rats. Regul. Pept. 2002, 105:29-34.
10. Domin J., Ghatei M.A., Chohan P., Bloom S.R. Neuromedin U: a study of its distribution in the rat. Peptides 1987, 8:779-784.
11. Ehlers C.L., Reed T.K., Henriksen S.J. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986, 42:467-474.
12. Garrick N., Hill A.J.L., Szele F.G., Tomai T.P., Gold P.W., Murphy D.L. Corticotropin-releasing factor: a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm. Endocrinology 1987, 121:1329-1334.
13. Gartlon J., Szekeres P., Pullen M., Sarau H.M., Aiyar N., Shabon U., Michalovich D., Steplewski K., Ellis C., Elshourbagy N., Duxon M., Ashmeade T.E., Harrison D.C., Murdock P., Wilson S., Ennaceur A., Atkins A., Heidbreder C., Hagan J.J., Hunter A.J., Jones D.N. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology 2004, 177:1-14.
14. Hanada R., Nakazato M., Murakami N., Sakihara S., Yoshimatsu H., Toshinai K., Hanada T., Suda T., Kangawa K., Matsukura S., Sakata T. A role for neuromedin U in stress response. Biochem. Biophys. Res. Commun. 2001, 289:225-228.
15. Hanada T., Date Y., Shimbara T., Sakihara S., Murakami N., Hayashi Y., Kanai Y., Suda T., Kangawa K., Nakazato M. Central actions of neuromedin U via corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 2003, 311:954-958.
16. Healey E.S., Kales A., Monroe L.J., Bixler E.O., Chamberlin K., Soldatos C. Onset of insomnia: role of life-stress events. Psychosom. Med. 1981, 43:439-451.
17. Hikosaka O., Nakamura K., Nakahara H. Basal ganglia orient eyes to reward. J. Neurophysiol. 2006, 95:567-584.
18. Honzawa M., Sudoh T., Minamino N., Tohyama M., Matsuo H. Topographic localization of neuromedin U-like structures in the rat-brain: an immunohistochemical study. Neuroscience 1987, 23:1103-1122.
19. Horvitz J.C. Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav. Brain Res. 2002, 137:65-74.
20. Hosoya M., Moriya T., Kawamata Y., Ohkubo S., Fujii R., Matsui H., Shintani Y., Fukusumi S., Habata Y., Hinuma S., Onda H., Nishimura O., Fujino M. Identification and functional characterization of a novel subtype of neuromedin U receptor. J. Biol. Chem. 2000, 275:29528-29532.
21. Howard A.D., Wang R., Pong S.S., Mellin T.N., Strack A., Guan X.M., Zeng Z., Williams D.L., Feighner S.D., Nunes C.N., Murphy B., Stair J.N., Yu H., Jiang Q., Clements M.K., Tan C.P., McKee K.K., Hreniuk D.L., McDonald T.P., Lynch K.R., Evans J.F., Austin C.P., Caskey C.T., Van der Ploeg L.H., Liu Q. Identification of receptors for neuromedin U and its role in feeding. Nature 2000, 406:70-74.
22. Hu Y., Dunbar J.C. Intracerebroventricular administration of NPY increases sympathetic tone selectively in vascular beds. Brain Res. Bull. 1997, 44:97-103.
23. Ivanov T.R., Lawrence C.B., Stanley P.J., Luckman S.M. Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 2002, 143:3813-3821.
24. Johnson E.N., Appelbaum Edward R., Carptenter D.C., Cox Richard F., Disa J., Foley J.J., Ghosh S.K., Naselsky D.P., Pullen M.A., Sarau M.S., Scheff S.R., Steplewski K.M., Meirav Zaks-Zilberman M.Z., Aiyar N. Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1. J. Immunol. 2004, 173:7230-7238.
25. Kawai T., Shibata A., Kurosawa K., Sato Y., Kato S., Ohki K., Hashimoto T., Sakura N. Structure-activity relationships of neuromedin U. V: Study on the stability of porcine neuromedin U-8 at the C-terminal asparagine amide under mild alkaline and acidic conditions. Chem. Pharm. Bull. 2006, 54:659-664.
26. Kojima M., Haruno R., Nakazato M., Date Y., Murakami N., Hanada R., Matsuo H., Kangawa K. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem. Biophys. Res. Commun. 2000, 276:435-438.
27. Liu J.J., Payza K., Huang J., Liu R., Chen T., Coupal M., Laird J.M., Cao C.Q., Butterworth J., Lapointe S., Bayrakdarian M., Trivedi S., Bostwick J.R. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2. J. Pharmacol. Exp. Ther. 2009, 330:268-275.
28. Marrosu F., Gessa G.L., Giagheddu M., Fratta W. Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res. 1990, 515:315-318.
29. Matsumura K., Abe I., Tsuchihashi T., Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R1314-R1320.
30. Matsumura K., Tsuchihashi T., Abe I. Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension 2001, 37:1382-1387.
31. Minamino N., Kangawa K., Matsuo H. Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 1985, 130:1078-1085.
32. Minamino N., Kangawa K., Honzawa M., Matsuo H. Isolation and structural determination of rat neuromedin U. Biochem. Biophys. Res. Commun. 1988, 156:355-360.
33. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 1980, 14:69-97.
34. Mondal M.S., Date Y., Toshinai K., Shimbara T., Kangawa K., Nakazato M. Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G963-G969.
35. Nakahara K., Hanada R., Murakami N., Teranishi H., Ohgusu H., Fukushima N., Moriyama M., Ida T., Kangawa K., Kojima M. The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. Biochem. Biophys. Res. Commun. 2004, 318:156-161.
36. Nakazato M., Hanada R., Murakami N., Date Y., Mondal M.S., Kojima M., Yoshimatsu H., Kangawa K., Matsukura S. Central effects of neuromedin U in the regulation of energy homeostasis. Biochem. Biophys. Res. Commun. 2000, 277:191-194.
37. Nandha K.A., Benito-Orfila M.A., Smith D.M., Bloom S.R. Characterization of the rat uterine neuromedin U receptor. Endocrinology 1993, 133:482-486.
38. Nicola S.M. The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology 2007, 191:521-550.
39. Obal F., Opp M., Cady A.B., Johannsen LF., Krueger J.M. Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits. Brain Res. 1989, 490:292-300.
40. Obal F., Payne L., Kacsoh B., Opp M., Kapás L., Grosvenor C.E., Krueger J.M. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide (VIP). Brain Res. 1994, 645:143-149.
41. O'Harte F., Bockman P.W., Abel C.S., Conlon J.M. Isolation, structural characterization and pharmacological activity of dog neuromedin U. Peptides 1991, 12:11-15.
42. Ozaki Y., Onaka T., Nakazato M., Saito J., Kanemoto K., Matsumoto T., Ueta Y. Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 2002, 143:4320-4329.
43. Pawlyc A.C., Sanford L.D., Brennan F.X., Morison A.R., Ross R.J. Corticotropin-releasing factor microinjection into the central nucleus of the amygdala alters REM sleep. Pharmacol. Rep. 2006, 58:125-130.
44. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego, USA.
45. Quan H., Funabashi T., Furuta M., Kimura F. Effects of neuromedin U on the pulsatile LH secretion in ovarictomized rats in association with feeding conditions. Biochem. Biophys. Res. Commun. 2003, 311:721-727.
46. Raddatz R., Wilson A.E., Artymyshyn R., Bonini J.A., Borowsky B., Boteju L.W., Zhou S., Kouranova E.V., Nagorny R., Guevarra M.S., Dai M., Lerman G.S., Vaysse P.J., Branchek T.A., Gerald C., Forray C., Adham N. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem. 2000, 275:32452-32459.
47. Rodenbeck A., Huether G., Rüther E., Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci. Lett. 2002, 324:159-163.
48. Sakura N., Ohta S., Uchida Y., Kurosawa K., Okimura K., Hashimoto T. Structure-activity relationships of rat neuromedin U for smooth muscle contraction. Chem. Pharm. Bull. 1991, 3:2016-2020.
49. Schulz P., Steimer T. Neurobiology of circadian systems. CNS Drugs 2009, 23(Suppl. 2):3-13.
50. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., Kannan H. Sympathetic and cardiovascular actions of orexin in conscious rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999, 277:R1780-R1785.
51. Tanida M., Satomi J., Shen J., Nagai K. Autonomic and cardiovascular effects of central neuromedin U in rats. Physiol. Behav. 2009, 96:282-828.
52. Vettor R., Fabris R., Pagano C., Federspil G. Neuroendocrine regulation of eating behavior. J. Endocrinol. Invest. 2002, 25:836-854.
53. Vgontzas A.N., Tsigos C., Bixler E.O., Stratakis C.A., Zachman K., Kales A., Vela-Bueno A., Chrousos G.P. Chronic insomnia and activity of the stress system: a preliminary study. J. Psychosom. Res. 1998, 45:21-31.
54. Wren A.M., Small C.J., Abbott C.R., Jethwa P.H., Kennedy A.R., Murphy K.G., Stanley S.A., Zollner A.N., Ghatei M.A., Bloom S.R. Hypothalamic actions of neuromedin U. Endocrinology 2002, 143:4227-4234.